Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Richman currently holds 244,400 shares of Opexa Therapeutics, Inc. (OPXA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Richman has been a net neutral trader of OPXA stock. They have purchased $0 and sold $0 worth of shares.
Michael Richman's most recent insider trade was on Mar 29, 2024, when they sold 244,400 shares at $0.00 per share.
Michael Richman serves as Executive at Opexa Therapeutics, Inc. (OPXA). They have executed 14 insider transactions totaling $0 over their tenure at the company.
Michael Richman holds the position of Executive at Opexa Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Michael Richman has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Michael Richman was on Jun 16, 2017, when they sold $8.6K worth of GNVC shares. This transaction involved 2,250 shares at $3.80 per share.
Michael Richman currently owns 244,400 shares of Opexa Therapeutics, Inc. (OPXA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Richman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Richman has 14 Form 4 filings on record as an insider at Opexa Therapeutics, Inc..
Set alerts for Michael Richman and 40,000+ other insiders.